Judy Chou
Director/Board Member presso AKERO THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Posizioni attive di Judy Chou
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AKERO THERAPEUTICS, INC. | Director/Board Member | 12/07/2021 | - |
| Independent Dir/Board Member | 12/07/2021 | - | |
Altrubio, Inc.
 Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| President | - | - |
Storia della carriera di Judy Chou
Precedenti posizioni note di Judy Chou
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 26/08/2019 | 19/11/2020 |
Bayer Pharmaceuticals
 Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Bayer Pharmaceuticals operates as a German pharmaceuticals company. The private company is based in Leverkusen, Germany. | Corporate Officer/Principal | - | - |
Formazione di Judy Chou
| Yale University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Germania | 2 |
Posizioni
| Director/Board Member | 3 |
| Doctorate Degree | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AKERO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Retail Trade |
Bayer Pharmaceuticals
Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Bayer Pharmaceuticals operates as a German pharmaceuticals company. The private company is based in Leverkusen, Germany. | Health Technology |
- Borsa valori
- Insiders
- Judy Chou
- Esperienza
